Completeness of data
| Models without serum creatinine | Models including serum creatinine | |||||||
|---|---|---|---|---|---|---|---|---|
| Number of risk predictors not recorded (per patient) | Moderate-severe chronic kidney disease | End-stage kidney failure | Moderate-severe chronic kidney disease | End-stage kidney failure | ||||
| Females (n = 784 005) | Males (n = 797 740) | Females (n = 790 929) | Males (n = 802 577) | Females (n = 784 005) | Males (n = 797 740) | Females (n = 790 929) | Males (n = 802 577) | |
| 0 | 549 661 (70.11) | 497 451 (62.36) | 554 747 (70.14) | 500 988 (62.42) | 83 096 (10.60) | 73 713 (9.24) | 87 229 (11.03) | 76 394 (9.52) |
| 1 | 182 448 (23.27) | 186 015 (23.32) | 184 132 (23.28) | 187 137 (23.32) | 494 580 (63.08) | 450 176 (56.43) | 496 953 (62.83) | 451 894 (56.31) |
| 2 | 23 597 (3.01) | 45 621 (5.72) | 23 686 (2.99) | 45 721 (5.70) | 156 173 (19.92) | 161 683 (20.27) | 156 509 (19.79) | 162 016 (20.19) |
| 3 | 7864 (1.00) | 12 794 (1.60 | 7904 (1.00) | 12 839 (1.60) | 22 387 (2.86) | 44 233 (5.54) | 22 436 (2.84) | 44 292 (5.52) |
| 4 | 20 435 (2.61) | 55 859 (7.00) | 20 460 (2.59) | 55 892 (6.96) | 7948 (1.01) | 12 920 (1.62) | 7975 (1.01) | 12 951 (1.61) |
| 5 | — | — | — | — | 19 821 (2.53) | 55 015 (6.90) | 19 827 (2.51) | 55 030 (6.86) |